cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Merck Co Inc
292 own
165 watching
Current Price
$95.55
$-1.08
(-1.12%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
297,738.7M
52-Week High
52-Week High
134.63000
52-Week Low
52-Week Low
94.48000
Average Volume
Average Volume
10.2M
Dividend Yield
Dividend Yield
0.031859
P/E Ratio
P/E Ratio
28.6667
iconMarket Capitalization297,738.7M
icon52-Week High134.63000
icon52-Week Low94.48000
iconAverage Volume10.2M
iconDividend Yield0.031859
iconP/E Ratio28.6667
What does the Merck Co Inc do?
Merck & Co., Inc. provides healthcare solutions worldwide. It operates in four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances segments. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, and fertility diseases. It also offers neuromuscular blocking agents; anti-bacterial products; cholesterol modifying medicines; and vaginal contraceptive products. In addition, the company offers products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat brain tumors; treat melanoma and metastatic non-small-cell lung cancer; prevent diseases caused by human papillomavirus; and vaccines for measles, mumps, rubella, varicella, chickenpox, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it offers antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics and vaccines for fishes. Additionally, the company offers companion animal products, such as ointments for acute and chronic otitis; diabetes mellitus treatment for dogs and cats; anthelmintic products; fluralaner products to treat fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. It serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, physician distributors, veterinarians, distributors, animal producers, and managed health care providers. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Read More
How much money does Merck Co Inc make?
News & Events about Merck Co Inc.
Globe Newswire
1 year ago
Essential Pharma appoints Lee Morley as Non-Executive Director to the Board Zug, Switzerland & Egham, UK 21 June 2023 Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically well-established pharmaceutical products...
Ticker Report
1 year ago
Builder Investment Group Inc. ADV bought a new stake in Merck Co., Inc. (NYSE:MRK Get Rating) in the fourth quarter, HoldingsChannel reports. The firm bought 7,743 shares of the companys stock, valued at approximately $859,000. A number of other institutional investors and hedge...
Ticker Report
1 year ago
ST Germain D J Co. Inc. lifted its stake in Merck Co., Inc. (NYSE:MRK Get Rating) by 39.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities Exchange Commission. The institutional investor owned 52,516 shares of the company&#...
Accesswire
1 year ago
NORTHAMPTON, MA / ACCESSWIRE / June 16, 2023 / Merck & Co., Inc.In underserved and under-resourced communities across the globe, from the U.S. to Rwanda, our company is helping patients at risk for and living with cancer access the care they need to stay well and lead fulfilling lives.We...
Business Wire
1 year ago
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-811 trial investigating KEYTRUDA, Mercks anti-PD-1 therapy, in combination with trastuzumab and chemotherapy met one of its dual primary endpoints of progression-free survival (PFS) for...
Frequently Asked Questions
Frequently Asked Questions
What is Merck Co Inc share price today?
plus_minus_icon
Can Indians buy Merck Co Inc shares?
plus_minus_icon
How can I buy Merck Co Inc shares from India?
plus_minus_icon
Can Fractional shares of Merck Co Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Merck Co Inc stocks?
plus_minus_icon
What is today’s traded volume of Merck Co Inc?
plus_minus_icon
What is today’s market capitalisation of Merck Co Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Merck Co Inc?
plus_minus_icon
What percentage is Merck Co Inc down from its 52-Week High?
plus_minus_icon
What percentage is Merck Co Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$95.55
$-1.08
(-1.12%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Johnson & Johnson
Johnson & Johnson
$146.82
$0.18 (0.12 %)
General Electric Company
General Electric Company
$196.75
$-4.05 (-2.02 %)
Bristol-Myers Squibb Co.
Bristol-Myers Squibb Co.
$59.67
$0.53 (0.90 %)
Texas Instruments Inc.
Texas Instruments Inc.
$185.56
$-15.05 (-7.50 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Johnson & Johnson
Johnson & Johnson
$146.82
$0.18 (0.12 %)
General Electric Company
General Electric Company
$196.75
$-4.05 (-2.02 %)
Bristol-Myers Squibb Co.
Bristol-Myers Squibb Co.
$59.67
$0.53 (0.90 %)
Texas Instruments Inc.
Texas Instruments Inc.
$185.56
$-15.05 (-7.50 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00